Signaling Pathway
Biosynthesis Pathway
There are no current examples of pathogens targeting this pathway.
â—„
1 / 1
â–º
AvrPtoB
AvrPtoB is a type III effector from Pseudomonas syringae strains. de Torres-Zabala et al., 2007 has shown that expression of avrPtoB leads to increased abscisic acid biosynthesis through activation of the NCED3 enzyme and decreased defense gene expression upon bacterial inoculation.
â—„
1 / 1
â–º
ABA biosynthetic pathway: The synthesis of ABA being in the plastid and involves the carotenoid zeaxanthin being converted to trans-violaxanthin by the enzyme ZEP/ABA1. The conversion from all-trans-violaxanthin to 9-cis-violaxanthin by a currently unknown enzymatic reaction. Following this conversion, NCED cleaves 9-cis-violaxanthin into xanthoxin, which is considered to be the rate limiting step of this reaction. In the cytosol, xanthoxin is to abscisic aldehyde by SDR/ABA2 and then oxidized to ABA by AAO. Lastly, the molybdenum cofactor is added to ABA by MOCO/ABA3. Arrows indicate positive interaction; blunt-end indicates negative interaction (inhibition).
ABA signaling pathway: ABA signaling starts with ABA being perceived by a PYR/PYL/RCAR receptor protein complex. When ABA is absent the PYR/PYL/RCR proteins are dimers, therefore when ABA is recognized the dimers disassociate. This disassociation leads to conformational changes on the PYR/PYL/RCAR proteins that allows for the formation of a binding site for PP2Cs. The binding of PP2Cs to the PYR/PYL/RCAR complex is followed by a release of the PP2C targets SnRK2s. This release allows the SnRK2s to translocate to the nucleus and phosphorylate the AREB/ABF class bZIP transcription factors that lead to activation of ABA-regulated genes. Arrows indicate positive interaction; blunt-end indicates negative interaction (inhibition).
